🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase 2 open-label study will evaluate the safety and effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-05-28
Trial ID
NCT04262856
Treatments Being Tested
The primary objective of this study is to compare the effect of zimberelima...
Status
Active Not Recruiting
Location
Innovative Clinical Research Institute
Start Date
2022-10-12
Trial ID
NCT05502237
Treatments Being Tested
This is a phase 2 study to evaluate zimberelimab (AB122) combined with domv...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-02-08
Trial ID
NCT04736173
Treatments Being Tested
The goal of this platform clinical trial is to test how well novel treatmen...
Status
Active Not Recruiting
Location
Arizona Oncology Associates,Substudy-02
Start Date
2023-03-16
Trial ID
NCT05633667
This study is being done to test the safety and effectiveness of combining ...
Status
Suspended
Location
Dana Farber Cancer Institute
Start Date
2022-11-30
Trial ID
NCT05419479
Treatments Being Tested
This randomized Phase 3 open-label study will compare the efficacy of the T...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-11-21
Trial ID
NCT05568095
Treatments Being Tested
This is a Phase III, randomised, double-blind, placebo-controlled, multicen...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-02-18
Trial ID
NCT05211895
Treatments Being Tested
The main goal of this study is to establish the proportion of patients with...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2022-03-16
Trial ID
NCT05130177
Treatments Being Tested
This is a Phase 1, multicenter, open-label, dose-escalation study to evalua...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2018-09-12
Trial ID
NCT03628677
Treatments Being Tested
This is a phase 1, non-randomized open-label, multicenter platform study de...
Status
Recruiting
Location
A site selected by Taiho Pharmaceutical Co., Ltd.
Start Date
2021-06-01
Trial ID
NCT04999761